Omega 3 Supplementation and Ocular Surface Disease in Glaucoma

Withdrawn before enrolling · Not applicable

Conditions studied: Ocular Surface Disease

In brief

Ocular surface disease (OSD) is a significant health problem that affects more than 10 million persons in the United States alone. OSD is highly prevalent among medically treated patients with glaucoma and is associated with the number of intraocular pressure (IOP)-lowering medications used. The purpose of this study is to determine the potential effectiveness of anoritega-3 fatty acid nutritional supplement in the treatment of ocular surface disease associated"with the use of glaucoma eye drops

Key facts

Study ID

NCT01630551

Run by

University of Illinois at Chicago

People needed

0

Starts

2012-04-01

Expected to finish

2017-02-01

Last updated by the study team

2017-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Typical symptoms of dry eye (photophobia, burning, foreign body sensation, blurred vision improved with blinking)
• OSDI score > 12
• Schirmer Test with Anesthesia < 8 mm/5 minutes
• Fluorescein tear break-up time < 8 seconds
• No current use of dry eye treatment (except artificial lubrication)

You may not qualify if…

• Infectious keratoconjunctivitis or inflammatory disease unrelated to dry eye or topical glaucoma medication use
• Patients with severe tear deficiency (defined as Schirmer tes <5 mm/5 min)
• Concomitant ocular pathology
• History of ocular surgery
• Eyelid or eyelash abnormalities
• Alteration of the nasolacrimal apparatus
• Treatment with drugs affecting tearing
• Treatment with vitamin supplements
• Concomitant ocular therapies
• Topical ophthalmic steroids taken during the 4 weeks before the study
• Pregnant/breast-feeding women
• Women who may be pregnant at the baseline visit or may become pregnant during the 90 days of therapy
• Diabetes
• History of fish and/or shellfish allergy or hypersensitivity

Where it is running

• Glaucoma Service, Department of Ophthalmology and Visual Science — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.